Webinar

Highly Potent Oral Solids: Challenges And Considerations

Pfizer-

The number and potency of highly potent drug substances are increasing. Formulators working with highly potent active pharmaceutical ingredients (APIs) are challenged to ensure the safety of personnel during development and manufacturing and healthcare workers and patients when using the final drug products. That means addressing potential issues with the homogeneity of the formulation, drug content analysis, and proper handling. In the manufacture of highly potent compounds, special consideration needs to be given to the technical and organizational controls that will ensure operator safety and minimize cross-contamination risks. Understanding product classification and the heightened complexity of transfer and manufacturing is critical to the success of bringing these highly potent medicines to patients in need.

Pfizer CentreOne's oral solids experts discuss key considerations for highly potent oral solids, focusing on three key challenges faced during development and manufacture. Discover more about the challenges and considerations when developing and manufacturing your highly potent oral solid.

Key learning objectives:

  • Understand the importance of containment strategies during manufacturing
  • Learn about key regulations relevant to highly potent oral solids
  • Explore the formulation challenges relating to highly potent oral solids
VIEW THE WEBINAR!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online